Updated October 24, 2026.

Generic semaglutide in Canada

Canada is the first large market with generic semaglutide. Here is what is actually on pharmacy shelves, what it costs, and how to keep track if you switch.

Timeline

DateEvent
January 2026Data protection on semaglutide ends in Canada, opening the market to generics.
April–May 2026Health Canada approves generics from Dr. Reddy's and Apotex.
May 14, 2026Apotex launches Apo-Semaglutide Injection in 2 mg and 4 mg pens.
September 2026Sandoz receives approval; launch date not yet announced.

What it costs

Apotex's wholesale price was $78.14 for a four-week supply, compared with $240.48 for brand Ozempic, according to The Globe and Mail. Reported pharmacy cash prices in October 2026 are about $83 to $103 per pen, before any insurance. Under the pan-Canadian generic pricing framework, prices are expected to fall further as more manufacturers launch.

Questions to ask your pharmacist

Do not change medication or dose without talking to your prescriber or pharmacist.

Keep a record when you switch

If you move between brand and generic, note the date, the product and the price. A log makes it easy to compare cost and any change in how you feel.

Frequently asked questions

Is generic semaglutide available in Canada?

Yes. Canada was the first major market where generic semaglutide became possible, after data protection ended in January 2026. Apotex launched Apo-Semaglutide in May 2026. Other manufacturers, including Dr. Reddy's and Sandoz, have Health Canada approvals; availability varies.

What is the generic approved for?

The generic injection pens reference Ozempic and are approved for once-weekly treatment of adults with type 2 diabetes. Ask your prescriber whether it is appropriate for you.

Can my pharmacist switch me automatically?

Substitution rules differ by province and by plan. Your pharmacist can tell you whether your prescription can be filled with a generic and what it will cost.